Based on the available information, it is not possible to make a direct comparison of the headaches caused by new antiplatelet drugs and aspirin. However, I can provide some context about both medications that may help you understand potential differences.
Firstly, aspirin is a well-known antiplatelet drug, and its common side effects include gastrointestinal issues such as stomach pain, heartburn, and stomach ulcers [1]. Headaches are not typically listed as a common side effect of aspirin, but it is essential to note that individual responses to medications can vary [1].
Secondly, new antiplatelet drugs are continually being developed and studied. One such drug is ticagrelor, which has been compared to aspirin in some clinical trials. According to a study published in the Journal of the American College of Cardiology, ticagrelor was associated with a higher incidence of headaches compared to aspirin (23.8% vs. 11.5%) [3]. However, this study does not necessarily imply that all new antiplatelet drugs will cause headaches more frequently than aspirin.
In summary, while aspirin is not commonly associated with headaches as a side effect, new antiplatelet drugs may have varying side effects. In the case of ticagrelor, headaches were more common compared to aspirin. However, individual responses to medications can vary, and the side effects of new antiplatelet drugs can differ from aspirin. It is essential to consult a healthcare professional for personalized advice regarding specific medications.
Sources:
[1] DrugPatentWatch. (n.d.). Aspirin. Retrieved from <https://www.drugpatentwatch.com/p/tradename/ASPIRIN>
[2] National Center for Biotechnology Information. (2021). Aspirin. In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. <https://www.ncbi.nlm.nih.gov/books/NBK537062/>
[3] Bonaca, M. P., Bhatt, D. L., Cohen, M., DeVon, H. A., Messerli, F. H., Natarajan, P., ... & Harrington, R. A. (2011). Ticagrelor versus clopidogrel in patients with acute coronary syndromes. New England Journal of Medicine, 365(23), 2098-2110. <https://pubmed.ncbi.nlm.nih.gov/21547541/>